Dimethyl Fumarate Delayed-Release

Strengths & Sizes

Note: product and packaging images are not actual size

NDC#31722-657-31
UPC Code331722657310
ImprintH/ D12

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-658-32
UPC Code331722658324
ImprintH/ D15

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-680-60
UPC Code331722680608
Imprint120mg: H / D12 | 240mg: H / D15

Download Label

Download HDA Sheet

Indications

Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Product Info

Dosage FormCapsule

TE CodeAB

Brand ReferenceTecfidera

Therapeutic CategorySelective immunosuppressant

Pronunciationdye METH il FUE mar ate

Inactive Ingredientscalcium silicate, colloidal silicon dioxide, croscarmellose sodium, gelatin, magnesium stearate, methacrylic acid and ethyl acrylate copolymer, methacrylic acid and methyl methacrylate copolymer, poloxamer, polysorbate 80, silicified microcrystalline cellulose, sodium bicarbonate, sodium lauryl sulfate, talc, titanium dioxide and triethyl citrate. In addition, the 120 mg capsules also contain FD&C Blue 1, iron oxide black and iron oxide yellow. The imprinting ink contains the following inactive ingredients: black iron oxide, potassium hydroxide, propylene glycol, shellac and strong ammonia solution.